Conexeu Sciences Inc. (CNXU) insider trading.
In Q3 2026, insiders at Conexeu Sciences Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.
- Transactions
- 4
- Purchases (P)
- 0
- Sales (S)
- 0
- Net shares, P minus S
- 0
- Insiders
- 3
- Last filed
- 2026-09-28
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Purcell Lynn Sebastian | Director, TenPercentOwner | 2 | 0 | 0 |
| Bogart David Robert | Director, Officer · Chief Commercial Officer | 1 | 0 | 0 |
| Sharpe Jeffrey Nathan | Director | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-25 | Bogart David Robert | M (A) | 750,000 | $0 | 1,812,500 | Form 4 |
| 2026-09-14 | Sharpe Jeffrey Nathan | M (A) | 500,000 | $0 | 1,500,000 | Form 4 |
| 2026-09-04 | Purcell Lynn Sebastian | X (A) | 217,608 | $2.3 | 2,951,848 | Form 4 |
| 2026-09-04 | Purcell Lynn Sebastian | X (A) | 217,608 | $2.3 | 2,951,848 | Form 4/A |
Transaction codes in this quarter
Get CNXU insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2066836&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · CNXU company page · Conexeu Sciences Inc. on SEC.gov
Questions
Are insiders buying or selling Conexeu Sciences Inc. (CNXU)?
In Q3 2026, insiders at Conexeu Sciences Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Conexeu Sciences Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/cnxu.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.